1. Fatty n-acyl-CoA derivatives in the concentration range 5,M-O.1mM and with 5-18 fatty acyl carbons have dual effects on phosphate-activated glutaminase from pig brain and kidney. Generally, fatty acyl-CoA derivatives in low concentrations activate the enzyme, but inhibit at higher concentrations; phosphate and citrate potentiate the activation, displaying positive co-operativity, and protect against inactivation. The fatty acyl-CoA derivatives affect glutaminase similarly to Bromothymol Blue, but differently from acetyl-CoA, which activates the enzyme only at very low phosphate or citrate concentrations. 2. Saturated fatty acyl-CoA derivatives, with 5-10 fatty acyl carbons, only activate the enzyme in the concentration range 0-0.1 mm. When the fatty acyl chain is elongated, the fatty acyl-CoA derivatives gradually become more powerful inhibitors of glutaminase at the expense of their activating capacity. In particular, palmitoyl-CoA and stearoyl-CoA are strong inhibitors at concentrations (10p.M) at which the corresponding free fatty acids and fatty acyl-carnitine derivatives have no effect. 3. The unsaturated fatty acyl-CoA derivatives, oleoyl-CoA and linoleoyl-CoA, behave as potent activators in the lower part of the concentration range tested (0-0.05mM), and as inhibitors in the upper part of this range (0.02-0.10mM). Oleic acid and linoleic acid have similar properties, but their activating capacity is less pronounced. 4. Phosphate both prevented and reversed the inhibition, but no restoration of activity was possible once the enzyme became inactivated. 5. By changing the pH from 7.0 to 8.0 the activating capacity of the fatty acyl-CoA derivatives is increased, as is their concentration range for activation. 6. The fatty acyl-CoA derivatives are somewhat more potent activators for brain glutaminase, but otherwise they affect the two enzymes similarly.
Pig kidney and brain phosphate-activated glutaminase (EC 3.5.1.2; L-glutamine amidohydrolase) purified to apparent homogeneity Svenneby et al., 1973) is activated by a range of different compounds Svenneby, 1970 Svenneby, , 1972 Weil-Malherbe & Beall, 1970; Tveit et al., 1970; Weil-Malherbe, 1972) . Among these, the dye Bromothymol Blue is particularly interesting because it behaves as an activator at concentrations below 50uM, and as an inhibitor when the concentration is increased. Moreover, phosphate potentiates the activation by the dye, and protects against inhibition. It has been shown that Bromothymol Blue probably acts as an activator by increasing the affinity of the enzyme for anionic activators (Kvamme et al., 1965 ; Kvamme & Torgner, 1974a,b) . In a search for natural compounds showing the Bromothymol Blue type of action, it has recently been demonstrated that palmitoyl-CoA, as well as stearoyl-CoA, affects glutaminase in a manner similar to that of Bromothymol Blue. However, at low phosphate concentrations (<7mM) and pH7.0, these compounds act predominantly as inhibitors (Kvamme & Torgner, Vol. 149 1974b) . The effect of palmitoyl-CoA and stearoylCoA on glutaminase is completely different from that of acetyl-CoA (Kvamme & Torgner, 1974a) , because the activation by acetyl-CoA is maximally effective in the absence of phosphate.
In the present paper, the effects of acyl-CoA derivatives with 5-18 fatty acyl carbons are described. In principle they all show the Bromothymol Blue type of action on glutaminase. However, the relationship between their activating and inhibiting properties varies with their fatty acyl residue. Generally, acyl-CoA derivatives are more effective inhibitors when the fatty acyl chain is elongated and more effective activators on unsaturation of the fatty acyl group. Experimental Materials L-Glutamine and Hepes [2-(N-2-hydroxyethylpiperazin-N'-yl) ethanesulphonic acid] were products of Sigma Chemical Co., St. Louis, Mo., U.S.A. The fatty n-acyl-CoA derivatives were obtained from P-L Biochemicals Inc., Milwaukee, Wis., U.S.A.
Methods
Phosphate-activated glutaminase from pig kidney and pig brain was purified as described previously Svenneby et al., 1973) . The second Tris-HCl-solubilized fraction [specific activity about 40units (1 unit is defined as 1 umol of NH3 formed/min per mg of protein)] was used in this work.
Glutaminase was assayed by measuring the amount of glutamate formed during 5min at 23°C; unless otherwise stated, the pH was 7.0. The reaction mixture (0.5ml) contained 40mM-L-glutamine, 3mM-EDTA, 15mM-Hepes and 0.01mg of protein. The enzyme reaction was stopped by the addition of 1 ml of cold (0°C) ethanol. Controls were treated in the same manner for the determination of nonenzymically hydrolysed glutamine, except that the enzyme was added after the addition of ethanol. Glutamate was isolated by paper chromatography and measured quantitatively as described previously (Kvamme & Torgner, 1974a) .
Protein was determined by the method of Layne (1957) .
Results

Effect offatty acyl-CoA derivatives on glutaminase
The fatty acyl-CoA derivatives with five or more fatty acyl carbons that we have investigated exert dual actions on glutaminase (Fig. 1) . Whether the acyl-CoA derivatives have activating or inhibiting effects on the enzyme depends both on the acyl-CoA concentration and on the concentration of phosphate and other anionic compounds, e.g. citric acid-cycle intermediates, in the assay. Thus phosphate and to a minor extent citric acid-cycle intermediates potentiate the activation and protect against inactivation by the acyl-CoA derivatives in question, which behave similarly to Bromothymol Blue in this respect, and differently from acetyl-CoA.
Valeryl-CoA (5 carbons) and octanoyl-CoA (8 carbons) which are the CoA derivatives with the shortest saturated fatty acyl chain in this experimental series, show only activating effects in the concentration range 0-0.10mM ( Fig. la and Table 1 ). The inhibiting effect first becomes visible for decanoylCoA (10 carbons) at the highest concentration used (Fig. lb) . When the fatty acyl chain contains more than 10 carbons, the fatty acyl-CoA derivatives activate only in the presence of high phosphate concentrations (25mM). Moreover, the concentration range for activation shifts towards lower concentrations and becomes increasingly narrow (Figs. lc, Id and 2a) . This is quantitatively expressed in Table 1 Figs. 3a and 3b). Among the physiological compounds tested, these CoA derivatives appear to have the greatest resemblance to Bromothymol Blue with respect to the effect on both kidney and brain glutaminase.
By increasing the pH of the incubation medium from 7.0 to 8.0 the activating power of acyl-CoA derivatives becomes considerably more pronounced, and inhibition occurs at higher concentrations (Figs. 2c, 4a and 4b) . Thus at pH8.0 and with 7mM or less phosphate present palmitoyl-CoA and stearoyl-CoA activate kidney glutaminase in the lower part of the concentration range tested (Fig. 2c ), whereas at pH 7.0 they inhibit the enzyme under these conditions (Fig. 2a) .
Effect offatty acids on glutaminase
The saturated fatty acids with chain lengths up to 10 carbon atoms have no effect on glutaminase, as shown in Table 1 for the kidney enzyme. Saturated fatty acids with 12-14 carbon atoms inhibit glutaminase, but their 150 values are much higher than the values for the corresponding CoA derivatives, indicating that the latter compounds are more powerful inhibitors (Table 1) . It should be noted that palmitic acid and stearic acid have no effect on glutaminase, in contrast with their CoA derivatives.
On the other hand, the concentration-activity plots of long-chain unsaturated fatty acids are of the Bromothymol Blue type, although their activating power is less pronounced than that of their 1975 0.05 (1.7-2.0)
(1.3-1.4) 1.2 1.6 2.5 1.7 2. Interactions between fatty acyl-CoA derivatives and other activators
As described above, phosphate potentiates the activation by long-chain acyl-CoA derivatives. Citrate and a-oxoglutarate have similar effects which are less pronounced than for phosphate. Fig. 4(b) demonstrates the potentiation by citrate compared with that by phosphate of the activation by linoleoyl-CoA.
Plots of enzyme activity versus acyl-CoA concentration, however, are more or less signoidal, indicating positive co-operativity at low concentrations (Fig. 4b) of fatty acyl-CoA (Fig. 4c) as well as inhibiting ones (Kvamme & Torgner, 1974b) , the plots intersect at one point on the ordinate, suggesting competition between phosphate and fatty acyl-CoA derivatives.
Reversibility of the inhibition of glutaminase by acyl-CoA derivatives and unsaturatedfatty acids
As demonstrated in the Figures, phosphate counteracts the inhibition of glutaminase by acylCoA derivatives and the unsaturated fatty acids oleic acid and linoleic acid, but it cannot be decided from these data whether phosphate reverses the inhibition or if it only protects against irreversible inactivation. In the latter case, the inhibition would be expected to be of minor physiological importance. However, the apparent competition between phosphate and fatty acyl-CoA derivatives, which is described above, suggests that the effect of fatty acyl-CoA derivatives on glutaminase is reversible. To investigate this further glutaminase was preincubated with inhibiting concentrations of the compounds and with no phosphate added, followed by assay with and without the addition of excess of phosphate. Table 2 demonstrates that the inhibition by low concentrations of fatty acyl-CoA derivatives or by unsaturated fatty acids is reversed by phosphate, whereas higher concentrations inhibit the enzyme irreversibly. However, phosphate is much more effective when added together with the inhibitor instead of after it, so that phosphate appears not only to reverse the inhibition, but also to protect against inactivation. No restoration of activity was possible, e.g. by extensive dialysis against Hepes-EDTA buffer, once the enzyme became inactivated.
It has been reported that inhibition by palmitoylCoA of some enzymes is reversed by their substrates, e.g. glucose 6-phosphate reverses the inhibition of glucose 6-phosphate dehydrogenase (Takata & Pogell, 1966) . As shown in Table 3 , glutamine does not prevent the inhibition of glutaminase by palmitoyl-CoA orstearoyl-CoA. Even ifthe glutamine concentration is increased from 0.5mM to 20.0mM, thepercentage inhibition ofglutaminase isunchanged, e.g. about 60% in the presence of 0.01 mM-palmitoylCoA. In accordance with this, it has previously been found that the inhibition by palmitoyl-CoA and stearoyl-CoA is non-competitive with glutamine (Kvamme & Torgner, 1974b Table. The preincubation mixture contained also 20mM-Hepes and 4mM-EDTA. Thereafter the enzyme was assayed as described in Table 1 (5min at 23°C and pH7.0) with and without the addition of phosphate. Water was added to the controls which did not contain phosphate. By these additions the enzyme was diluted 10°/O and by the subsequent addition of glutaminase a total dilution of 25% resulted, which, however, did not affect the results. The experiments were repeated three times and the results are expressed as the ratio of the activity with inhibitor present to that without. Table 3 . Non-protective effect by the substrate glutamine ofthe inhibition ofglutaminase by acyl-CoA derivatives Pig kidney glutaminase was incubated with 10mM-phosphate, and with glutamine, palmitoyl-CoA and stearoyl-CoA as indicated in the Table. The experimental conditions were otherwise as in Table 1 Discussion Palmitoyl-CoA in concentrations 0.1-1O0uM has previously been found to irreversibly inhibit many mammalian enzymes, e.g. glutamate dehydrogenase, malate dehydrogenase, fumarase, ar-glycerophosphate dehydrogenase, glucose 6-phosphate dehydrogenase and 6-phosphogluconate dehydrogenase (Takata & Pogell, 1966) , as well as yeast and bacterial fatty acid synthetases (Knoche et al., 1973) . However, the inhibition of glucose 6-phosphate dehydrogenase and 6-phosphogluconate dehydrogenase was competitive and reversible with respect to their substrates, so that the inhibition may have some physiological importance in the regulation of the activity of these Vol. 149 enzymes. Moreover, palmitoyl-CoA inhibits mitochondrial adenine nucleotide translocase (Pande & Blanchaer, 1971 ) and long-chain acyl-CoA synthetase from rat liver (Pande, 1973) in a fully reversible manner. Apart from the effects of palmitoyl-CoA, little information is available about the effects of other long-chain acyl-CoA derivatives on mammalian enzyme activities.
Activation of mammalian enzymes by long-chain fatty acyl-CoA derivatives has, to our knowledge, not been described previously, but activation of phosphoenolpyruvate carboxykinase of Escherichia coli by free fatty acids such as laurate and oleate, and by their CoA derivatives, has been found (Izui et al., 1970) . Thus it is noteworthy that mitochondrial glutaminase is strongly activated by many fatty acyl-CoA derivatives, both saturated and unsaturated, in the lowest concentration range in which they show any effect, and that the activation is potentiated by other anions, such as phosphate. At higher concentrations, but within a very narrow range, the long-chain fatty acyl-CoA derivatives that we have investigated, become inhibitors, and the inhibition is reversed by phosphate. At still higher concentrations, the inhibition becomes irreversible, but this effect is probably of little physiological interest.
Fatty acyl-CoA derivatives with 5-18 fatty acyl carbon atoms also affect phosphate-activated glutaminase from kidney and brain differently from acetyl-CoA, because phosphate or citrate in concentrations higher than 10mM and 100mM respectively abolish the activation by acetyl-CoA (Kvamme & Torgner, 1974a) . Since it is unlikely that the phosphate concentration in the mitochondrial matrix space ever falls below 5mM, and acetyl-CoA is increasingly effective when the substrate concentration decreases, it may thus secure a certain minimum glutaminase activity at phosphate concentrations in the range 5-10mM and at low glutamine concentrations.
Saturated fatty acyl-CoA derivatives with 5-18 fatty acyl carbons become more potent inhibitors with increasing numbers of acyl carbons, and more potent activators when the acyl chain becomes shorter. Thus the activation may be due to interaction with hydrophilic groups on the enzyme, whereas the increasing hydrophobicity of the longer fatty acyl chains may cause the inhibition. In keeping with this, the unsaturated acyl-CoA derivatives with 18 fatty acyl carbons, oleoyl-CoA and linoleoyl-CoA, aremore potent activators and less potent inhibitors than the corresponding saturated derivative, palmitoyl-CoA.
Similarly to Bromothymol Blue (Kvamme & Torgner, 1974a) , the 5-18-carbon fatty acyl-CoA derivatives, both in activating (Fig. 4c) and inhibiting concentrations (Kvamme & Torgner, 1974b) , affect mainly the apparent Km value for phosphate with little or no change in the Vmax., and they appear thus to affect the binding of anions to the anionic activating sites on glutaminase. Moreover, the affinity of fatty acyl-CoA derivatives for inhibiting hydrophobic binding sites on the enzyme seems to be lower than that for the neighbouring activating hydrophilic binding sites. In accordance with this, the acyl-CoA derivatives appear not to affect the binding sites for the substrate glutamine, because glutamine does not protect against inhibition by these compounds.
With respect to the physiological importance of the effects of fatty acyl-CoA derivatives of glutaminase, no conclusions can, of course, be drawn from experiments in vitro alone. Moreover, Morei et al. (1974) emphasize the high, and unspecific, acceptance capacity of biological membranes for acyl-CoA derivatives. In vivo there are also problems of compartmentalization and local concentrations to be taken into account. However, the reversible effects on glutaminase of acyl-CoA derivatives, as described in this and a previous paper (Kvamme & Torgner, 1974a) , open up the possibility of a very refined metabolic regulation, linking NH3 production and amino acid metabolism to lipid oxidation. Apart from the interaction of acyl-CoA derivatives with, for example, phosphate or citrate, regulation of glutaminase activity is also possible by increasing the chain length of the fatty acyl-CoA derivatives, by splitting off the CoA or by replacing it with carnitine, by a change in H+ concentration and by unsaturation of the acyl moiety.
Further, it is known that the intramitochondrial concentrations of long-chain fatty acyl-CoA derivatives undergo great variations, depending both on the nutritional state of the animal and on the organ in question. Thus the long-chain fatty acyl-CoA concentrations of rat liver mitochondria vary in the range 0.1-0.5nmol/mg of protein (Garland et al., 1965) . If confined to the mitochondrial matrix, like phosphate-activated glutaminase (Crompton et al., 1973) , local concentrations may be well within the effective range for these derivatives.
Preliminary experiments in our laboratory show that palmitoyl-carnitine exerts a concentrationdependent effect on glutaminase in intact pig kidney mitochondria, which is not seen in experiments with the purified enzyme, indicating that acyl-CoA derivatives formed from palmitoyl-camitine are permitted to enter the mitochondrial matrix space where glutaminase is localized.
It should be noted that free fatty acids are major fuels of the kidney (Gold & Spitzer, 1964; Nieth & Schollmeyer, 1966) . In chronic metabolic acidosis increased amounts of NH3 are formed from glutamine (Shalhoub et al., 1963; Owen & Robinson, 1963) and an activation of glutaminase has been discussed (Rector et al., 1965; Damian & Pitts, 1970) . It has also been reported that glutaminase becomes more sensitive to activation by phosphate under these conditions. At any rate, the well-known increased concentrations of acyl-CoA derivatives in diabetic acidosis may explain the activation of glutaminase in this type of acidosis.
